文献速递关节外科

单次注射与连续收肌管阻滞用于全膝关节置换术后镇痛的前瞻性随机开放标签研究

A prospective randomized open-label study of single injection versus continuous adductor canal block for postoperative analgesia after total knee arthroplasty.
PubMed 文献 · Bone Joint J · 2019-01-01

该前瞻性随机开放标签研究将159例拟行初次全膝关节置换术的ASA I至III级患者随机分为三组:单次收肌管阻滞组(A组,n=53)、24小时连续输注组(B组,n=51)和48小时连续输注组(C组,n=52),最终156例完成分析。结果显示,术后第2天报告严重疼痛(疼痛评分7至10分)的患者比例分别为21%、14%和12%(p=0.05),48小时累积阿片类药物需求量和功能结局三组相似。结论认为24小时或48小时连续输注较单次收肌管阻滞在主要终点上无明确获益,但留置导管48小时在减少中度疼痛患者数量和改善疼痛管理质量方面有边缘性获益。

要点

  • 术后第2天严重疼痛(评分7至10分)比例:单次组21%、24小时组14%、48小时组12%(p=0.05)。
  • 48小时累积阿片类药物需求量三组相似。
  • 术后第1天和第2天功能结局三组相似。

核心结论

  • 24小时或48小时连续输注较单次收肌管阻滞在主要终点上无明确获益。
  • 留置导管48小时在减少中度疼痛患者数量和改善疼痛管理质量方面有边缘性获益。
  • 三组阿片类药物使用、住院时间和功能结局相似。

研究设计与样本

  • 前瞻性、随机、非盲法研究,纳入159例拟行初次全膝关节置换术的ASA I至III级患者,随机分为三组,3例未完成研究,最终156例纳入分析。
  • A组为单次注射组(n=53,女16例、男37例,平均年龄63.9岁(sd 9.6))。
  • B组为24小时输注组(n=51,女22例、男29例,平均年龄66.5岁(sd 8.5))。
  • C组为48小时输注组(n=52,女18例、男34例,平均年龄62.2岁(sd 8.7))。

主要发现

  • 术后第2天报告严重疼痛(疼痛评分7至10分)的患者比例:单次注射组21%、24小时输注组14%、48小时输注组12%(p=0.05)。
  • 48小时累积阿片类药物需求量三组相似。
  • 术后第1天和第2天功能结局三组相似。

局限性

  • 需要更大样本量的进一步研究来确认这些发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Adductor canal block (ACB) has emerged as an alternative to femoral nerve block (FNB) for analgesia after total knee arthroplasty (TKA). The optimal duration of maintenance of the ACB is still questionable. The purpose of this study was to compare the analgesic benefits and physiotherapy (PT) outcomes of single-shot ACB to two different regimens of infusion of the continuous ACB, 24-hour and 48-hour infusion. PATIENTS AND METHODS: This was a prospective, randomized, unblinded study. A total of 159 American Society of Anesthesiologists (ASA) physical status I to III patients scheduled for primary TKA were randomized to one of three study groups. Three patients did not complete the study, leaving 156 patients for final analysis. Group A (n = 53) was the single-shot group (16 female patients and 37 male patients with a mean age of 63.9 years (sd 9.6)), group B (n = 51) was the 24-hour infusion group (22 female patients and 29 male patients with a mean age of 66.5 years (sd 8.5)), and group C (n = 52) was the 48-hour infusion group (18 female patients and 34 male patients with a mean age of 62.2 years (sd 8.7)). Pain scores, opioid requirements, PT test results, and patient-reported outcome instruments were compared between the three groups. RESULTS: The proportion of patients reporting severe pain, defined as a pain score of between 7 and 10, on postoperative day number 2 (POD 2) were 21% for the single-shot group, 14% for the 24-hour block group, and 12% for the 48-hour block group (p = 0.05). Cumulative opioid requirements after 48 hours were similar between the groups. Functional outcomes were similar in all three groups in POD 1 and POD 2. CONCLUSION: There was no clear benefit of the 24-hour or 48-hour infusions over the single-shot ACB for the primary endpoint of the study. Otherwise, there were marginal benefits for keeping the indwelling catheter for 48 hours in terms of reducing the number of patients with moderate pain and improving the quality of pain management. However, all three groups had similar opioid usage, length of hospital stay, and functional outcomes. Further studies with larger sample sizes are needed to confirm these findings. Cite this article: Bone Joint J 2019;101-B:340-347.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Elkassabany NM, Cai LF, Badiola I, et al. A prospective randomized open-label study of single injection versus continuous adductor canal block for postoperative analgesia after total knee arthroplasty. Bone Joint J. 2019. PMID: 30813800. doi:10.1302/0301-620X.101B3.BJJ-2018-0852.R2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。